FORA

Forian Inc.
3 filings tracked
healthcarehealthcare analyticsMICRO (<$300M)

Signal Magnitude Chart

BEARISH | 70% | 3/27/2026 | margin compressionBULLISH | 90% | 3/27/2026 | debt restructureBULLISH | 60% | 3/27/2026 | acquisitionBEARISH | 50% | 3/27/2026 | regulatory actionBULLISH | 90% | 5/15/2026 | acquisitionBEARISH | 80% | 5/15/2026 | margin compressionBEARISH | 70% | 5/15/2026 | earnings missBULLISH | 60% | 5/15/2026 | debt restructureBULLISH | 90% | 5/15/2026 | acquisitionBEARISH | 80% | 5/15/2026 | margin compressionBEARISH | 70% | 5/15/2026 | earnings missBULLISH | 60% | 5/15/2026 | debt restructureMar 26May 26HIGHLOW
bullish
bearish
neutral

Signal Timeline

bullishMay 15

Definitive merger agreement for $2.17 per share.

acquisition
90%
bearishMay 15

Gross margins collapsed from 56% to 29% due to rising licensing costs.

margin compression
80%
bearishMay 15

Net loss widened to $3.36 million for the quarter.

earnings miss
70%
bullishMay 15

Full redemption of convertible notes, leaving the company debt-free.

debt restructure
60%
bullishMay 15

Definitive merger agreement for $2.17 per share.

acquisition
90%
bearishMay 15

Gross margins collapsed from 56% to 29% due to rising licensing costs.

margin compression
80%
bearishMay 15

Net loss widened to $3.36 million for the quarter.

earnings miss
70%
bullishMay 15

Full redemption of convertible notes, leaving the company debt-free.

debt restructure
60%
bearishMar 27

Gross margins fell from 64% to 53% due to higher licensing and processing costs.

margin compression
70%
bullishMar 27

Full redemption of convertible notes, leaving the company debt-free.

debt restructure
90%
bullishMar 27

Acquisition of Kyber Data Science expanded revenue into financial services.

acquisition
60%
bearishMar 27

Disclosure of material weakness in internal controls over revenue recognition (ASC 606).

regulatory action
50%

Filing History

10-QMay 15, 2026

Forian's latest filing presents a stark contrast between a deteriorating operating business and a highly attractive corporate exit. While the core business is struggling with margin compression and customer attrition, the company's strategic move to eliminate debt and accumulate cash has made it a prime target for acquisition. The tension for investors lies in whether the $2.17 per share offer represents a fair exit or a speculative gamble on a sinking ship. The overall impact of the filing is the transition of FORA from a growth-oriented data analytics play to a special-situation arbitrage trade. The primary catalyst is no longer organic growth, but the successful closing of the merger agreement amidst emerging legal challenges from shareholders. Investors must now weigh the certainty of the cash-rich balance sheet against the volatility of the company's operational decline and the potential for litigation to delay the transaction.

10-KMar 27, 2026

The 10-K filing reveals a company at a crossroads, balancing aggressive inorganic growth against structural operational risks. The acquisition of Kyber has undeniably expanded Forian's addressable market and revenue base, but it has also introduced margin pressure and increased the complexity of its data sourcing. The total elimination of convertible debt is a major victory for the balance sheet, providing the liquidity necessary to navigate these transitions. Investors must now weigh the potential for operating leverage against the systemic risks of data dependency and internal control failures. While the shift toward positive Adjusted EBITDA is a positive signal, the ability of the company to maintain its data licenses and fix its revenue accounting will be the true determinants of long-term viability. The overall impact of the filing is a shift from solvency risk to execution risk.